New Therapeutic Option for Patients with metastatic castration-resistant Prostate Cancer Talazoparib in combination with Enzalutamide prolongs progression-free Survival

被引:0
|
作者
Ruedesheim, Sabine M.
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:161 / 161
页数:1
相关论文
共 50 条
  • [11] Enzalutamide (formerly MDV3100) prolongs survival in docetaxelpretreated castration-resistant prostate cancer patients
    Heck, Matthias M.
    Gschwend, Juergen E.
    Retz, Margitta
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2013, 2 (02) : 92 - 93
  • [12] Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer
    Yang, Xiaobing
    Zhao, Jiahui
    Wei, Dechao
    Feng, Tao
    Guo, Pengju
    Li, Qiankun
    Wang, Yongxing
    Han, Yili
    Li, Mingchuan
    Jiang, Yongguang
    Luo, Yong
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (08) : 760 - 770
  • [13] Re: Enzalutamide and Survival in Non-metastatic Castration-resistant Prostate Cancer
    Bagguley, Dominic
    Ong, Sean
    Lawrentschuk, Nathan
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2021, 79 (02) : 320 - 321
  • [14] Enzalutamide for Patients with castration-resistant Prostate Cancer
    Kessing, Richard
    AKTUELLE UROLOGIE, 2020, 51 (01)
  • [15] Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
    Sternberg, Cora N.
    Fizazi, Karim
    Saad, Fred
    Shore, Neal D.
    De Giorgi, Ugo
    Penson, David F.
    Ferreira, Ubirajara
    Efstathiou, Eleni
    Madziarska, Katarzyna
    Kolinsky, Michael P.
    Cubero, Daniel I. G.
    Noerby, Bettina
    Zohren, Fabian
    Lin, Xun
    Modelska, Katharina
    Sugg, Jennifer
    Steinberg, Joyce
    Hussain, Maha
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23): : 2197 - 2206
  • [16] Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer
    Lorente, David
    Castro, Elena
    Lozano, Rebeca
    Puente, Javier
    Romero-Laorden, Nuria
    Rodriguez-Vida, Alejo
    Lainez, Nuria
    Villatoro, Rosa
    Llacer, Casilda
    Cattrini, Carlo
    Hernandez, Amaia
    Domenech, Montserrat
    Zambrana, Francisco
    Almagro, Elena
    Luque, Raquel
    Martinez, Esther
    Lopez-Campos, Fernando
    Gonzalez, Belen
    Jose Mendez-Vidal, Maria
    Medina, Ana
    Maria Piulats, Josep
    Olmos, David
    EUROPEAN UROLOGY, 2020, 77 (06) : 763 - 766
  • [17] Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort
    Rouyer, Magali
    Oudard, Stephane
    Joly, Florence
    Fizazi, Karim
    Tubach, Florence
    Jove, Jeremy
    Lacueille, Clementine
    Lamarque, Stephanie
    Guiard, Estelle
    Balestra, Aurelie
    Droz-Perroteau, Cecile
    Fourrier-Reglat, Annie
    Moore, Nicholas
    Abdiche, Samir
    Angellier, Elisabeth
    Beal-Ardisson, Dominique
    Bera, Guillaume
    Berdah, Jean-Francois
    Bernard, Olivier
    Blanc, Anne-Sophie
    Bonnet, Isabelle
    Borde, Florence
    Bosset, Mathieu
    Brocard, Fabien
    Cailleres, Sylvie
    Carlier, Damien
    Carola, Elisabeth
    Clippe, Christine
    Dagada, Corinne
    Darut-Jouve, Ariane
    Dauba, Jerome
    Dolmazon, Christine
    Dube, Patrick
    El Demery, Mounira
    Evon, Philippe
    Guichard, Francois
    Hasbini, Ali
    Hoch, Benjamin
    Hu, Ludmila
    Laguerre, Brigitte
    Laharie, Hortense
    Lemoine, Nathalie
    Levasseur, Nadia
    Louvet, Christophe
    Molnar, Delia
    Moullet, Isabelle
    Nahon, Sophie
    Oudard, Stephane
    Prevost, Jean-Briac
    Priou, Frank
    BRITISH JOURNAL OF CANCER, 2019, 121 (12) : 1001 - 1008
  • [18] PSA progression compared to radiographic or clinical progression in metastatic castration-resistant prostate cancer patients treated with enzalutamide
    Gandhy, Shruti U.
    Karzai, Fatima
    Marte, Jennifer L.
    Bilusic, Marijo
    McMahon, Sheri
    Strauss, Julius
    Couvillon, Anna
    Williams, Monique
    Hankin, Amy
    Steinberg, Seth M.
    Figg, William Douglas
    Arlen, Philip M.
    Dahut, William L.
    Gulley, James L.
    Madan, Ravi Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [19] Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort
    Magali Rouyer
    Stéphane Oudard
    Florence Joly
    Karim Fizazi
    Florence Tubach
    Jérémy Jove
    Clémentine Lacueille
    Stéphanie Lamarque
    Estelle Guiard
    Aurélie Balestra
    Cécile Droz-Perroteau
    Annie Fourrier-Reglat
    Nicholas Moore
    British Journal of Cancer, 2019, 121 : 1001 - 1008
  • [20] Treatment of Metastatic Castration-resistant Prostate Cancer With Abiraterone and Enzalutamide Despite PSA Progression
    Becker, Daniel J.
    Iyengar, Arjun D.
    Punekar, Salman R.
    Ng, Jason
    Zaman, Anika
    Loeb, Stacy
    Becker, Kevin D.
    Makarov, Danil
    ANTICANCER RESEARCH, 2019, 39 (05) : 2467 - 2473